Medical (Therapy, Education and Research) Act

Company Profile for Paragonix Technologies

Retrieved on: 
Friday, June 19, 2020
Cardiology, Health, Packaging, Medical devices, Other Transport, Logistics, Supply chain management, Transport, Manufacturing, Medical specialties, Medicine, Organ donation, Surgery, Pancreas, Organ, Medical (Therapy, Education and Research) Act, Organ transplantation, Transplantation medicine, Histidine-tryptophan-ketoglutarate

Paragonix Technologies designs, produces, and sells organ preservation and transport devices that safeguard organs during the journey between donor and recipient patients.

Key Points: 
  • Paragonix Technologies designs, produces, and sells organ preservation and transport devices that safeguard organs during the journey between donor and recipient patients.
  • The Paragonix SherpaPak systems incorporate clinically proven and medically trusted cold preservation techniques in a novel suspension system to provide unprecedented physical and thermal protection.
  • Paragonix SherpaPak CTS is the only commercially available FDA cleared and CE marked transport device for heart preservation.
  • Paragonix is also developing transport devices for the lung, pancreas, kidney and liver designed to improve donor organ quality and extend donor organ transport time.

TransMedics to Present at the Cowen 40th Annual Health Care Conference

Retrieved on: 
Thursday, February 20, 2020
Medical specialties, Medicine, Transmedics, Surgery, Organ transplantation, Organ donation, Medical (Therapy, Education and Research) Act, Transplantation medicine

ANDOVER, Mass., Feb. 20, 2020 (GLOBE NEWSWIRE) -- TransMedics Group, Inc. (TransMedics) (Nasdaq: TMDX), a medical technology company that is transforming organ transplant therapy for patients with end-stage lung, heart and liver failure, today announced the company will be participating in the upcoming Cowen 40th Annual Health Care Conference in Boston.

Key Points: 
  • ANDOVER, Mass., Feb. 20, 2020 (GLOBE NEWSWIRE) -- TransMedics Group, Inc. (TransMedics) (Nasdaq: TMDX), a medical technology company that is transforming organ transplant therapy for patients with end-stage lung, heart and liver failure, today announced the company will be participating in the upcoming Cowen 40th Annual Health Care Conference in Boston.
  • TransMedics management is scheduled to present on Tuesday, March 3, 2020 at 8:40 a.m. Eastern Time.
  • A live and archived webcast of the event will be available on the Investors section of the TransMedics website at www.transmedics.com .
  • TransMedics is the worlds leader in portable ex-vivo warm perfusion and assessment of donor organs for transplantation.

TransMedics to Present at the 38th Annual J.P. Morgan Healthcare Conference

Retrieved on: 
Thursday, December 19, 2019
Medicine, Transmedics, Organ transplantation, Organ donation, Medical (Therapy, Education and Research) Act, Transplantation medicine, Shaf Keshavjee

ANDOVER, Mass., Dec. 19, 2019 (GLOBE NEWSWIRE) -- TransMedics Group, Inc. (TransMedics) (Nasdaq: TMDX), a medical technology company that is transforming organ transplant therapy for patients with end-stage lung, heart and liver failure, today announced the company will present at the upcoming 38th Annual J.P. Morgan Healthcare Conference in San Francisco.

Key Points: 
  • ANDOVER, Mass., Dec. 19, 2019 (GLOBE NEWSWIRE) -- TransMedics Group, Inc. (TransMedics) (Nasdaq: TMDX), a medical technology company that is transforming organ transplant therapy for patients with end-stage lung, heart and liver failure, today announced the company will present at the upcoming 38th Annual J.P. Morgan Healthcare Conference in San Francisco.
  • TransMedics management is scheduled to present on Wednesday, January 15, 2020 at 3:30 p.m. Pacific Time.
  • A live and archived webcast of the presentation and breakout session will be available on the Investors section of the TransMedics website at www.transmedics.com .
  • TransMedics is the worlds leader in portable ex-vivo warm perfusion and assessment of donor organs for transplantation.

Donate Life America and the Fresenius Medical Care Foundation Announce Groundbreaking National, Universal Living Donor Kidney Registry

Retrieved on: 
Tuesday, October 22, 2019
Medical specialties, Medicine, Clinical medicine, Organ donation, Organ transplantation, Donate Life America, Kidney transplantation, Fresenius, Medical (Therapy, Education and Research) Act, National Kidney Registry, National Marrow Donor Program

WALTHAM, Mass., Oct. 22, 2019 /PRNewswire/ -- Donate Life America (DLA) and the Fresenius Medical Care Foundation (Foundation) today announced a unique partnership, launching a groundbreaking national, universal living donor kidney registry and at-home testing kitto improve access to living donation for the 95,000 people on the national transplant wait list currently waiting for a life-saving kidney transplant.

Key Points: 
  • WALTHAM, Mass., Oct. 22, 2019 /PRNewswire/ -- Donate Life America (DLA) and the Fresenius Medical Care Foundation (Foundation) today announced a unique partnership, launching a groundbreaking national, universal living donor kidney registry and at-home testing kitto improve access to living donation for the 95,000 people on the national transplant wait list currently waiting for a life-saving kidney transplant.
  • The initiatives launching in 2020 include:
    The National Donate Life Living Donor Registry: The first national, universal living donor registry will offer the opportunity for the public to register their interest in becoming a living donor, reducing the barriers that currently exist with no clear pathway to express interest.
  • This new living donor registry will be built as part of the already existing, secured and trusted National Donate Life Registry that houses deceased organ, eye and tissue donor registrations.
  • To learn more about the partnership between Donate Life America and the Fresenius Medical Care Foundation, visit www.fmcna.com/foundation .

TransMedics to Present at the 17th Annual Morgan Stanley Global Healthcare Conference

Retrieved on: 
Monday, August 26, 2019
Medical specialties, Medicine, Transmedics, Surgery, Organ donation, Medical (Therapy, Education and Research) Act, Organ transplantation, Transplantation medicine

ANDOVER, Mass., Aug. 26, 2019 (GLOBE NEWSWIRE) -- TransMedics Group, Inc. (TransMedics) (Nasdaq: TMDX), a medical technology company that is transforming organ transplant therapy for patients with end-stage lung, heart and liver failure, today announced the company will be participating in the upcoming 17th Annual Morgan Stanley Global Healthcare Conference in New York.

Key Points: 
  • ANDOVER, Mass., Aug. 26, 2019 (GLOBE NEWSWIRE) -- TransMedics Group, Inc. (TransMedics) (Nasdaq: TMDX), a medical technology company that is transforming organ transplant therapy for patients with end-stage lung, heart and liver failure, today announced the company will be participating in the upcoming 17th Annual Morgan Stanley Global Healthcare Conference in New York.
  • TransMedics management is scheduled to present on Monday, September 9, 2019 at 4:15 p.m. Eastern Time.
  • A live and archived webcast of the event will be available on the Investors section of the TransMedics website at www.transmedics.com .
  • TransMedics is the worlds leader in portable ex-vivo warm perfusion and assessment of donor organs for transplantation.

OneLegacy Partners With Donate Life Hollywood to Bring Awareness of Organ, Eye and Tissue Donation During Panel Featuring Writers, Producers of NBC’s Hit Medical Drama Series “New Amsterdam”

Retrieved on: 
Thursday, August 15, 2019
Women, Seniors, Parenting, MEN, TV and Radio, Gay & Lesbian, Family, Consumer, Entertainment, General Health, Surgery, Health, General Entertainment, Medical (Therapy, Education and Research) Act, Health, Organ transplantation, Healthcare in Australia, Articles

OneLegacy, the largest organ, eye and tissue recovery organization in the nation, recently hosted a special panel with top writers and producers of NBCs new medical drama series New Amsterdam.

Key Points: 
  • OneLegacy, the largest organ, eye and tissue recovery organization in the nation, recently hosted a special panel with top writers and producers of NBCs new medical drama series New Amsterdam.
  • View the full release here: https://www.businesswire.com/news/home/20190815005568/en/
    Writers and producers of NBCs new medical drama series "New Amsterdam" recently shared a panel at OneLegacys Donate Life Hollywood event, which focused on bringing television viewers authentic and accurate storylines concerning the power of organ, tissue and eye donation.
  • We also appreciate the support of the donation and transplantation community, which enables Donate Life Hollywood to bring together the medical and entertainment worlds to save lives.
  • Over 100 transplant and medical professionals who attended the Transplant Centers: Making a Difference event participated in this panel.